Exelixis Inc. Common Stock vs National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares — how do they compare? Exelixis Inc. Common Stock trades at $61.5 (market cap $15.12B), while National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares trades at $79.72 (market cap $78.99B). The key difference: National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares is far larger — about 5.2× Exelixis Inc. Common Stock's market cap, and National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares pays a 4.13% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals.
| EXEL | NGG | |
|---|---|---|
Market Cap | $15.12B | $78.99B |
Volume | 2,752,905 | 740,402 |
Sector | Health | Utilities |
52-Week High | $60.99 | $93.93 |
52-Week Low | $34.54 | $73.54 |
Typical Hold Time | 3 Days | — |
Enterprise Value | $14.44B | $137.22B |
Dividend Yield | — | 4.13% |
Signals from Pluang's Aura AI — not financial advice
EXEL trades at $59.51, down 0.52% on the day but near its 52-week high of $61.66 reached on October 12, 2026. The stock shows strong technical momentum with bullish moving averages and has consistently beaten earnings estimates in recent quarters. Recent news highlights include a three-month FDA review delay for zanzalintinib but continued growth in CABOMETYX revenue, which surpassed $3 billion annually.
The outlook remains positive with strong profitability metrics (35.33% net margin, 44.39% ROE) and projected revenue growth to $2.4 billion in 2026. Key risks include regulatory delays for new drug approvals and competitive pressures in oncology. Analyst consensus is mixed with 48% buy ratings but a price target of $52.33 suggesting potential downside from current levels.
National Grid (NGG) trades at $78.23, up 1.44% on the day, with a market cap of approximately $48.3 billion. The stock shows stable technicals near its consensus price target of $79.25. Fundamentally, it maintains strong profitability with an 18.32% net income margin and has beaten EPS estimates in recent quarters. Recent news highlights institutional buying and a focus on grid innovation, including AI adoption.
Outlook is cautiously positive with upside to the high target of $85.50, supported by earnings momentum and strategic investments. Risks include high debt levels and regulatory pressures. Analyst consensus leans buy (55%), but hold ratings reflect concerns over capital intensity and macroeconomic sensitivity.
Trailing returns across standard periods
Latest headlines on both assets
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →National Grid plc is a British utility company that owns and operates electricity and gas transmission networks in Great Britain, and through its US Regulated business, operates electricity and gas transmission and distribution networks serving customers in New York and Massachusetts. Its shares trade on the NYSE as American Depositary Shares under the ticker NGG.
Read more on NGG →